Rye Brook Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,000
Closed -$2.34M 29
2024
Q4
$2.34M Sell
17,000
-11,900
-41% -$1.74M 2.8% 14
2024
Q3
$4.45M Sell
28,900
-700
-2% -$106K 6.42% 8
2024
Q2
$4.31M Sell
29,600
-35,400
-54% -$5.08M 5.68% 7
2024
Q1
$9.6M Buy
+65,000
New +$9.32M 5.63% 7
2021
Q2
Sell
-14,450
Closed -$1.69M 31
2021
Q1
$1.69M Sell
14,450
-21,300
-60% -$2.46M 1.23% 17
2020
Q4
$4.05M Buy
+35,750
New +$3.9M 3.53% 12

Other funds holding XLV

Rye Brook Capital's XLV Position: Q1 2025 in Review

Rye Brook Capital sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2025, closing a stake of 17,000 shares — an estimated $2.34M sold.

Rye Brook Capital first reported a position in XLV in Q4 2020 and held it in 6 quarters. The position peaked at $9.6M in Q1 2024. 1,767 funds tracked by Wall St. Rank hold XLV as of Q1 2025.

  • Rye Brook Capital reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2025 after selling out during the quarter.
  • Rye Brook Capital sold 17,000 State Street Health Care Select Sector SPDR ETF shares in Q1 2025, an estimated $2.34M.
  • Rye Brook Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2020 and held it in 6 quarters.
  • Rye Brook Capital's State Street Health Care Select Sector SPDR ETF position peaked at $9.6M in Q1 2024.
  • 1,767 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2025.

Based on Rye Brook Capital's 13F filing for Q1 2025, filed 16 Apr 2025.